Total (n = 223) | Non-cirrhosis (LSM < 12.5 kPa) (n = 159) | Cirrhosis (LSM ≥ 12.5 kPa) (n = 64) | p value | |
---|---|---|---|---|
Socio-demographic characteristics | ||||
Age, years, mean (SD) | 37 (5) | 37 (5) | 38 (6) | 0.376 |
Male, n(%) | 204 (91.5) | 142 (89.3) | 62 (96.8) | 0.068 |
BMI, kg/m2, mean (SD) | 22.55 (3.80) | 22.26 (3.56) | 23.27 (4.27) | 0.071 |
IVDU history, n(%) | 208 (93.3) | 148 (93.1) | 60 (93.7) | 0.857 |
Alcohol history, n(%) | 159 (71.3) | 114 (71.7) | 45 (70.3) | 0.836 |
HBsAg seropositivity, n(%) | 8 (3.6) | 7 (4.4) | 1 (1.5) | 0.303 |
HIV characteristics | ||||
ART duration, years, median (IQR) | 6.8 (4) | 6.8 (5) | 6.8 (2) | 0.264 |
Current CD4, cells/mm3, median (IQR) | 508 (306) | 508 (333) | 508 (215) | 0.855 |
ART used | ||||
2NRTI + EFV, n(%) | 96 (43) | 76 (47.7) | 20 (31.2) | 0.011 |
2NRTI + NVP, n(%) | 94 (42.2) | 64 (40.2) | 30 (46.8) | |
2NRTI + LPV/r, n(%) | 33 (14.8) | 19 (11.9) | 14 (21.8) | |
HCV infection characteristics | ||||
HCV-RNA, log10, mean (SD) | 6.12 (0.81) | 6.15 (0.84) | 6.06 (0.73) | 0.453 |
Hemoglobin, g/dL, mean (SD) | 13.8 (2.3) | 13.9 (2.0) | 13.5 (2.8) | 0.201 |
Platelet, 103/mL, median (IQR) | 225 (77) | 249 (78) | 173 (72) | < 0.001 |
ALT, U/L, median (IQR) | 55 (51) | 50 (41) | 66.5 (71) | < 0.001 |
AST, U/L, median (IQR) | 41 (41) | 37 (25) | 71 (64) | < 0.001 |
eGFR (CKD-EPI), mL/min/1.73 m2, mean (SD) | 108.5 (21.3) | 108.5 (20.7) | 108.5 (23.0) | 0.998 |
LSM (kPa), median (IQR) | 8.8 (7.3) | 7.8 (3.8) | 20.1 (10.4) | < 0.001 |
APRI score, median (IQR) | 0.41 (0.52) | 0.34 (0.33) | 0.97 (1.25) | < 0.001 |
FIB-4 score, median (IQR) | 0.88 (0.73) | 0.81 (0.45) | 1.69 (1.76) | < 0.001 |